The Wistar Institute

Today's Discoveries, Tomorrow's Cures.

Medical advances begin as scientific advances. The Wistar Institute is an independent nonprofit biomedical research institute dedicated to saving lives through science.
Our Science >
New Technology for Enhancing Immunotherapy Identified

Hildegund C.J. Ertl and her lab demonstrated how a switch from glucose to fatty acid to generate energy enhances antitumor T cell activity.
Learn More >
Newly Identified Pathway Controls Tumor Metabolic Reprogramming

The lab of Dario Altieri described how the pathway may be targeted to disrupt metastatic tumor cells.
Learn More >
Link Established Between Novel Class of Drugs and Melanoma Progression

The lab of Ashani Weeraratna describes the interplay of autophagy and a key pathway regulating melanoma progression and metastasis.
Learn More >
Novel Immunotherapy Technology for Prostate Cancer

David Weiner and his lab developed a new treatment method for prostate cancer utilizing synthetic DNA to encode protective antibodies against a specific cancer protein.
Learn More >

Connect with Wistar

Stay up-to-date with Wistar's exciting scientific discoveries and all of our upcoming events.

Wistar Shared Resources

Wistar's Shared Resources augment the power of individual labs with scientific expertise and technologies. They are available to all Wistar investigators, Wistar affiliates, and external researchers on a fee-for-service basis.

Find a Shared Resource >

Meet A Scientist

Qing Chen, M.D., Ph.D., focuses on brain metastasis, a significant clinical challenge due to its rising incidence and limited treatment options. She studies how cancer cells interact with surrounding brain cells to understand how a cancer can become metastatic.

More About Qing's Research >

Support Wistar

Your contribution directly supports Wistar scientists in their efforts to improve cancer medicine and create new vaccines.
Donate >

Giving options >

From The Wistar Wire

August 16, 2017

Career Transition: Reeti Behera, Ph.D., Continues Cancer Research by Applying What She Learned in Lab to Office

Reeti Behera, Ph.D., a talented postdoctoral fellow who has worked in the Weeraratna lab at Wistar since 2014, successfully made the career transition from hands-on bench scientist to a scientific program administrator for the American Association of Cancer Research (AACR). Read More >

August 16, 2017

Wistar Science Highlights: Ovarian Cancer Research, Melanoma Publication Award, Zika Science in Singapore

A new study from Wistar scientists has demonstrated a potential method for treating an aggressive type of ovarian cancer. A young scientist was honored for her melanoma research paper, while another traveled to Singapore to present new data about a Zika vaccine. Read More >

See All News

Press Releases

September 20, 2017

Characterization of a Slowly Proliferating Population of Melanoma Cells with High Metastatic Properties

These cells are able to leave the primary tumor and colonize distant sites at early stages of tumor progression. Read More >

September 19, 2017

Tumor-infiltrating B Lymphocytes Promote Melanoma Progression and Resistance to Therapy

Depletion of B cells in the tumor microenvironment shows antitumor activity in patients with advanced metastatic melanoma and could be used as a novel immunotherapeutic approach Read More >

See All Press Releases